Natural Medicaments Profile
Key Indicators
- Authorised Capital ₹ 1.40 Cr
- Paid Up Capital ₹ 4.83 M
- Company Age 29 Year, 3 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 7.08 M
- Satisfied Charges ₹ 0.68 M
- Revenue Growth 14.67%
- Profit Growth 29.88%
- Ebitda -38.09%
- Net Worth -128.33%
- Total Assets 0.15%
About Natural Medicaments
Natural Medicaments Limited (NML) is a Public Limited Indian Non-Government Company incorporated in India on 19 October 1995 and has a history of 29 years and three months. Its registered office is in Jabalpur, Madhya Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.40 Cr and a paid-up capital of Rs 4.83 M.
The company currently has active open charges totaling ₹7.08 M. The company has closed loans amounting to ₹0.68 M, as per Ministry of Corporate Affairs (MCA) records.
Prachi Jaiswal, Akshat Jaiswal, and Narendra Jaiswal serve as directors at the Company.
Company Details
-
Location
Jabalpur, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U27106MP1995PLC010077
-
Company No.
010077
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
19 Oct 1995
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Natural Medicaments?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Narendra Jaiswal | Managing Director | 01-Apr-2008 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Prachi Jaiswal | Whole-Time Director | 01-Apr-2010 | Current |
Akshat Jaiswal | Additional Director | 20-Aug-2020 | Current |
Financial Performance of Natural Medicaments.
Natural Medicaments Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 14.67% increase. The company also saw a substantial improvement in profitability, with a 29.88% increase in profit. The company's net worth observed a substantial decline by a decrease of 128.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Natural Medicaments?
In 2019, Natural Medicaments had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.71 Cr
₹0.07 Cr
Charges Breakdown by Lending Institutions
- Union Bank Of India : 0.60 Cr
- Allahabad Bank : 0.08 Cr
- Hdfc Bank : 0.03 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
15 Apr 2011 | Hdfc Bank | ₹0.30 M | Open |
03 Dec 2009 | Allahabad Bank | ₹0.78 M | Open |
16 May 2002 | Union Bank Of India | ₹3.00 M | Open |
08 May 1999 | Union Bank Of India | ₹0.50 M | Open |
05 May 1999 | Union Bank Of India | ₹2.50 M | Open |
How Many Employees Work at Natural Medicaments?
Unlock and access historical data on people associated with Natural Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Natural Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natural Medicaments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.